L. D. Bradford

G. Kirov, M. Owen, M. O’Donovan, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

A tethering system for intravenous and intragastric drug administration in the baboon

R. Griffiths, J. Brady, S. Lukas, 1982, Pharmacology Biochemistry and Behavior.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): Recruitment and assessment methods

B. Devlin, J. Ragland, R. Gur, 2006, Schizophrenia Research.

Unique CYP2D6 activity distribution and genotype‐phenotype discordance in black Americans

A. Gaedigk, J. Leeder, L. D. Bradford, 2002, Clinical pharmacology and therapeutics.

The Ethnopharmacology of Atypical Antipsychotics

L. D. Bradford, 2005, CNS Spectrums.

Self-injection of barbiturates and benzodiazepines in baboons

R. Griffiths, J. Brady, S. Lukas, 1981, Psychopharmacology.

Linkage analysis of schizophrenia in African-American families

L. Klei, B. Devlin, R. Gur, 2009, Schizophrenia Research.

Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons

R. Griffiths, J. Brady, L. D. Bradford, 1979, Psychopharmacology.

Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure.

L. Klei, B. Devlin, R. Yolken, 2012, Schizophrenia bulletin.

CYP2D6*36 GENE ARRANGEMENTS WITHIN THE CYP2D6 LOCUS: ASSOCIATION OF CYP2D6*36 WITH POOR METABOLIZER STATUS

A. Gaedigk, J. Leeder, S. Alander, 2006, Drug Metabolism and Disposition.

Persistent infection with neurotropic herpes viruses and cognitive impairment

L. Klei, B. Devlin, R. Yolken, 2012, Psychological Medicine.

Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients.

Raquel E Gur, Ruben C Gur, Bernie Devlin, 2010, The American journal of psychiatry.

Heritability of functioning in families with schizophrenia in relation to neurocognition

B. Devlin, R. Gur, M. Calkins, 2012, Schizophrenia Research.

Prevalence and Correlates of Depressive Symptoms and Resiliency among African American Women in a Community-Based Primary Health Care Center

Kisha B. Holden, S. Hall, L. D. Bradford, 2013, Journal of health care for the poor and underserved.

Psychosocial and sociocultural correlates of depressive symptoms among diverse African American women.

Henrie Treadwell, Kisha B. Holden, S. Hall, 2012, Journal of the National Medical Association.

Stigma and mental health in African Americans.

Kisha B. Holden, L. D. Bradford, C. Newkirk, 2009 .

Serenics: the pharmacology of fluprazine and DU 28412.

J. Schipper, L. D. Bradford, D. van Dalen, 1984, Progress in clinical and biological research.

Characterizing depression and comorbid medical conditions in African American women in a primary care setting.

Kisha B. Holden, L. D. Bradford, P. Baltrus, 2013, Journal of the National Medical Association.

CYP2D6 poor metabolizer status can be ruled out by a single genotyping assay for the -1584G promoter polymorphism.

Andrea Gaedigk, A. Gaedigk, J. Leeder, 2003, Clinical chemistry.

Behavioral assessment of risk-taking and psychophysical functions in the baboon.

J. Brady, R. Hienz, L. D. Bradford, 1979, Neurobehavioral toxicology.

Identification and Characterization of CYP2D6*56B, an Allele Associated with the Poor Metabolizer Phenotype

A. Gaedigk, S. Alander, L. D. Bradford, 2007, Clinical pharmacology and therapeutics.

Responding maintained by cocaine or d-amphetamine under fixed-interval schedules in baboons.

R. Griffiths, L. D. Bradford, 1980, Drug and alcohol dependence.

Cytochrome P4502D6 (CYP2D6) Gene Locus Heterogeneity: Characterization of Gene Duplication Events

I Zineh, J. Johnson, I. Zineh, 2007, Clinical pharmacology and therapeutics.

Untitled Page

L. D. Bradford, 2012 .

Discovery of a novel nonfunctional cytochrome P450 2D6 allele, CYP2D6*42, in African American subjects

Roger Gaedigk, Andrea Gaedigk, A. Gaedigk, 2003, Clinical pharmacology and therapeutics.

High frequency of CYP2D6 poor and "intermediate" metabolizers in black populations: a review and preliminary data.

A. Gaedigk, L. D. Bradford, L. Js, 1998, Psychopharmacology bulletin.

Limited Association of the 2988g>a Single Nucleotide Polymorphism with CYP2D6*41 in Black Subjects

A. Gaedigk, J. Leeder, L. D. Bradford, 2005, Clinical pharmacology and therapeutics.

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples

G. Kirov, M. Owen, M. O’Donovan, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.